Zepbound is a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist. It’s injected under the skin once a week in addition to diet and exercise for long-term weight management in adults with a body mass index (BMI) of:...
Mounjaro and Zepbound both contain tirzepatide, a dual-acting GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. GIP and GLP-1 are both natural incretin hormones. Mounjaro lowers fasting and postprandial (after meals) glucose concentration, dec...
Zepbound is the brand name for tirzepatide, a prescription weight management medication. FDA approved, this GIP and GLP-1 receptor agonist has shown amazing results in studies with patients losing 5-18% of their body weight in 52 weeks. While Zepbound is great for ...
Mounjaro and Ozempic are different drugs, although they work in a similar way. Mounjaro is a GLP-1 and GIP receptor agonist. Ozempic acts only on GLP-1. They’re both approved to lower blood sugar in people with type 2 diabetes in combination with a healthy diet and exercise. ...
The Zepbound brand of tirzepatide from Eli Lilly is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist used for weight loss in adults with obesity or who are overweight and have weight-related medical conditions.These...